title: [Treatment with lisinopril or nifedipine in essential hypertension. A Norwegian multicenter study of the effect, tolerance and quality of life of 828 patients].
abstract: In a randomized, parallel, double-blind study, lisinopril (n = 412) reduced systolic and diastolic blood pressure more than nifedipine did (n = 416) after ten weeks treatment in patients (40-70 years) with mild to moderate essential hypertension. Lisinopril was tolerated better than nifedipine, with fewer withdrawals. Adverse experiences reported after a general question on discomfort were significantly lower for lisinopril than for nifedipine. Questions referring specifically to symptoms revealed higher frequency of coughing with lisinopril, while flushing, edema, palpitations, dizziness, tiredness and rash were reported more frequently with nifedipine. Quality of life was similarly assessed by both patients and spouses. No significant differences in well-being during treatment were found for either drug, except in the case of the highest dose level of nifedipine, which caused a deterioration of well-being.
authors.affiliation: Medicinsk avdelning, Göteborgs Universitet.
authors.forename: J O
authors.initials: JO
authors.lastname: Syvertsen
authors.forename: B
authors.initials: B
authors.lastname: Bratland
authors.forename: B
authors.initials: B
authors.lastname: Dahlöf
authors.forename: K
authors.initials: K
authors.lastname: Gisholt
authors.forename: I
authors.initials: I
authors.lastname: Os
authors.forename: S
authors.initials: S
authors.lastname: Tretli
mesh_terms: D000328:Adult; D000368:Aged; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D003371:Cough / Q000139:chemically induced; D004151:Dipeptides / Q000009:adverse effects / Q000627:therapeutic use*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000523:psychology; D017706:Lisinopril; D008297:Male; D008875:Middle Aged; D009543:Nifedipine / Q000009:adverse effects / Q000627:therapeutic use*; D009664:Norway; D011788:Quality of Life
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D004151:Dipeptides; D017706:Lisinopril; D009543:Nifedipine
vernacular_title: Behandling med lisinopril eller nifedipin ved essensiell hypertensjon. En norsk multisenterstudie av effekt, toleranse og livskvalitet hos 828 pasienter.